# IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer

> **NCT00041223** · PHASE2 · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust**

## Conditions studied

- Breast Cancer
- Radiation Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** IH636 grape seed proanthocyanidin extract

## Key facts

- **NCT ID:** NCT00041223
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041223, "IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00041223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*